Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	86.22	57.26	80.93	178.27	305.74	233.35
Cash & Short-Term Investments	86.22	57.26	80.93	178.27	305.74	233.35
Cash Growth	46.50%	-29.24%	-54.60%	-41.69%	31.02%	70.51%
Accounts Receivable	17.98	10.23	15.22	28.21	23.11	23.93
Other Receivables	0.14	0.17	0.17	0.14	0.68	0.74
Receivables	18.13	10.4	15.39	28.35	23.79	24.67
Inventory	11.82	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	2.34	7.11	10.5	9.66	7.07	6.72
Other Current Assets	-	1.17	-	-	-	-
Total Current Assets	118.5	90.37	117.02	230.43	346.46	266.15
Property, Plant & Equipment	14.93	17.12	23.5	33.01	34.07	32.41
Long-Term Investments	-	-	-	-	-	17.57
Other Intangible Assets	28.67	31.86	20.29	27.2	12.55	14.63
Other Long-Term Assets	19.3	4.87	6.72	3.66	3.42	2.66
Total Assets	181.41	144.22	167.53	294.3	396.5	333.41
Accounts Payable	18.77	31.64	34.81	57.24	47.43	11.41
Accrued Expenses	23.99	30.74	34.68	36.51	39.99	31.26
Short-Term Debt	-	-	3.93	5	0.81	-
Current Portion of Long-Term Debt	5.63	0.63	3	7.24	4.51	4.52
Current Portion of Leases	2.13	2.62	2.52	2.45	2.1	1.85
Current Income Taxes Payable	1.01	0.93	0.84	0.72	0.35	0.14
Current Unearned Revenue	-	-	-	-	2.61	-
Other Current Liabilities	2.55	4.84	5.13	18.55	3.24	2.58
Total Current Liabilities	54.07	71.4	84.91	127.72	101.04	51.76
Long-Term Debt	47.77	57.96	60.86	93.14	46.56	59.81
Long-Term Leases	12.77	14.75	18.28	21.57	20.99	22.89
Other Long-Term Liabilities	1.62	1.76	1.89	1.85	2.03	1.95
Total Liabilities	116.22	145.87	165.94	244.28	170.63	136.41
Common Stock	0.03	0.03	0.02	0.01	0.1	0.1
Additional Paid-In Capital	785.94	763.57	717.4	675.94	656.03	583
Retained Earnings	-730.12	-740.87	-694.87	-634.23	-547.46	-482.76
Total Common Equity	55.86	22.73	22.54	41.72	108.67	100.34
Minority Interest	9.32	-24.38	-20.96	8.3	117.2	96.66
Shareholders' Equity	65.19	-1.64	1.59	50.03	225.88	197
Total Liabilities & Equity	181.41	144.22	167.53	294.3	396.5	333.41
Total Debt	68.29	75.96	88.59	129.4	74.98	89.08
Net Cash (Debt)	17.93	-18.7	-7.67	48.87	230.77	144.28
Net Cash Growth	-	-	-	-78.82%	59.95%	564.37%
Net Cash Per Share	0.67	-0.90	-0.95	8.25	42.37	30.06
Filing Date Shares Outstanding	31.04	29.53	19.23	8.65	6.97	6.33
Total Common Shares Outstanding	31.01	27.91	15.09	7.37	6.76	6.33
Working Capital	64.44	18.97	32.11	102.72	245.42	214.39
Book Value Per Share	1.80	0.81	1.49	5.66	16.07	15.86
Tangible Book Value	27.19	-9.13	2.25	14.52	96.12	85.71
Tangible Book Value Per Share	0.88	-0.33	0.15	1.97	14.21	13.55
Buildings	0.58	0.58	0.58	0.58	0.58	-
Machinery	1.61	1.61	1.61	10.76	8.68	7.61
Construction In Progress	-	-	0.03	0.95	2.03	0.5
Leasehold Improvements	3.29	11	13.18	13.18	13.18	10.58

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q